IDP.F
Biogen Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
183.22
▼ 5.78 (3.06%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
182.30
Prev close
189.00
Day high
183.22
Day low
182.30
Volume
100
Market cap
$27.07B
P/E (TTM)
38.01
52W range
112.65 – 189.62
Day trading desk
Gap from prior close
-3.54%
Prior close 189.00
VWAP
183.22
0.00% from price
Relative volume
2.22×
Unusually busy
Session range
0.50%
182.30 – 183.22
Position in range
100%
Near session high
ATR (14D)
3.70
2.02% of price
Prior day high
189.00
PDH
Prior day low
185.00
PDL
Bid / ask spread
—
Quote not published
Session volume
100
Avg 45
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.99%
+3.4%
1M
+6.05%
+2.3%
3M
+10.21%
+7.1%
6M
+10.51%
-0.6%
YTD
+22.11%
+9.8%
1Y
+53.45%
+33.5%
3Y
-25.34%
-99.5%
5Y
-28.08%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on IDP.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
277.78K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 4, 26 | MINOR LLOYD B. Director |
SELL | 1.19K | $239.75K | Direct |
| Jun 9, 26 | PANGALOS MENELAS N Director |
— | 2.37K | — | Direct |
| Jun 9, 26 | FREIRE MARIA C Director |
STOCK | 2.00K | $0 | Direct |
| Jun 9, 26 | MANTAS JESUS B Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | PATOLAWALA MONISH D Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | LANGER SUSAN Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | PANGALOS MENELAS N Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | MINOR LLOYD B. Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | HAWKINS WILLIAM A III Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | SHERWIN STEPHEN A Director |
STOCK | 1.50K | $0 | Direct |
| Jun 9, 26 | ROWINSKY ERIC K. Director |
STOCK | 1.50K | $0 | Direct |
| May 1, 26 | KEENEY ADAM JAMES Officer |
— | 939 | — | Direct |
| Apr 1, 26 | GODBOUT SEAN Officer |
— | 181 | — | Direct |
| Feb 12, 26 | MURPHY NICOLE Officer |
BUY | 3 | $585 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALEXANDER SUSAN H |
Officer | 61.89K | Conversion of Exercise of derivative security |
DORSA CAROLINE D |
Director | 31.00K | Stock Award(Grant) |
GREGORY GINGER |
Officer | 22.36K | Conversion of Exercise of derivative security |
KRAMER ROBIN C. |
Chief Financial Officer | 11.47K | Conversion of Exercise of derivative security |
MANTAS JESUS B |
Director | 11.26K | Stock Award(Grant) |
MCDONNELL MICHAEL R |
Chief Financial Officer | 24.34K | Conversion of Exercise of derivative security |
MURPHY NICOLE |
Officer | 19.61K | Purchase |
ROWINSKY ERIC K. |
Director | 25.84K | Stock Award(Grant) |
SHERWIN STEPHEN A |
Director | 15.19K | Stock Award(Grant) |
VIEHBACHER CHRISTOPHER |
Chief Executive Officer | 29.92K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$27.07B
Enterprise value$34.14B
Revenue (TTM)$10.03B
Gross profit$7.85B
EBITDA$3.36B
Net income$834.60M
EPS (TTM)$4.82
Free cash flow$1.27B
Total cash$1.28B
Total debt$8.36B
Book value / share$110.52
Shares outstanding147.75M
Float147.22M
Short % of float—
Dividend yield—
Beta (5Y)0.16
Valuation & profitability ratios
Trailing P/E38.01
Forward P/E8.87
PEG ratio1.51
Price / sales—
Price / book1.66
EV / revenue3.41
EV / EBITDA10.16
Gross margin78.32%
Operating margin25.06%
Profit margin8.32%
Return on equity4.58%
Return on assets5.21%
Debt / equity44.33
Current ratio1.87
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.89B | $9.68B | $9.84B | $10.17B | +2.2% |
| Operating revenue | $9.89B | $9.68B | $9.84B | $9.69B | +2.2% |
| Cost of revenue | $2.40B | $2.31B | $2.53B | $2.28B | +4.1% |
| Gross profit | $7.49B | $7.37B | $7.30B | $7.90B | +1.6% |
| Research & development | $1.78B | $1.98B | $2.45B | $2.23B | -10.2% |
| Selling, general & admin | $2.43B | $2.40B | $2.55B | $2.40B | +1.2% |
| Total operating expense | $5.02B | $5.09B | $5.45B | $4.99B | -1.3% |
| Operating income | $2.47B | $2.28B | $1.85B | $2.90B | +8.3% |
| Net interest income | -$142.50M | -$182.70M | $29.60M | -$157.30M | +22.0% |
| Pre-tax income | $1.56B | $1.91B | $1.30B | $3.59B | -18.3% |
| Tax provision | $263.60M | $273.80M | $135.30M | $632.80M | -3.7% |
| Net income | $1.29B | $1.63B | $1.16B | $3.05B | -20.8% |
| Net income to common | $1.29B | $1.63B | $1.16B | $3.05B | -20.8% |
| Basic EPS | 8.83 | 11.21 | 8.02 | 20.96 | -21.2% |
| Diluted EPS | 8.79 | 11.18 | 7.97 | 20.87 | -21.4% |
| EBIT | $1.82B | $2.16B | $1.54B | $3.84B | -15.4% |
| EBITDA | $2.60B | $2.83B | $2.04B | $4.36B | -8.0% |
| Basic shares | 146.50M | 145.60M | 144.70M | 145.30M | +0.6% |
| Diluted shares | 147.10M | 145.90M | 145.60M | 146.00M | +0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.01B | $2.38B | $1.05B | $3.42B | — | +26.7% |
| Cash & short-term investments | $3.82B | $2.38B | $1.05B | $4.89B | — | +60.7% |
| Accounts receivable | $1.87B | $1.87B | $2.10B | $2.14B | — | -0.1% |
| Inventory | $2.17B | $2.46B | $2.53B | $1.34B | — | -11.9% |
| Total current assets | $8.97B | $7.46B | $6.86B | $9.79B | — | +20.3% |
| Property, plant & equipment | $3.32B | $3.54B | $3.73B | $3.70B | — | -6.1% |
| Goodwill & intangibles | $15.67B | $16.17B | $14.58B | $7.60B | — | -3.1% |
| Total assets | $29.44B | $28.05B | $26.84B | $24.55B | — | +5.0% |
| Total current liabilities | $3.35B | $5.53B | $3.43B | $3.27B | — | -39.4% |
| Current debt | — | $1.75B | $150.00M | — | $999.10M | — |
| Long-term debt | $6.29B | $4.55B | $6.79B | $6.28B | — | +38.3% |
| Total debt | $6.58B | $6.63B | $7.34B | $6.61B | — | -0.8% |
| Total liabilities | $11.18B | $11.33B | $12.05B | $11.17B | — | -1.3% |
| Retained earnings | $20.55B | $19.26B | $17.63B | $16.47B | — | +6.7% |
| Shareholder equity | $18.26B | $16.72B | $14.80B | $13.40B | — | +9.2% |
| Working capital | $5.62B | $1.93B | $3.42B | $6.52B | — | +191.7% |
| Net tangible assets | $2.59B | $545.90M | $217.20M | $5.80B | — | +373.9% |
| Shares issued | 170.60M | 169.52M | 168.70M | 167.80M | — | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.29B | $1.63B | $1.16B | $2.96B | — | -20.8% |
| Depreciation & amortisation | $779.90M | $673.20M | $494.80M | $518.40M | — | +15.8% |
| Stock-based compensation | $290.80M | $291.20M | $264.20M | $254.10M | — | -0.1% |
| Change in working capital | -$1.06B | -$155.20M | -$648.70M | -$890.30M | — | -581.4% |
| Operating cash flow | $2.20B | $2.88B | $1.55B | $1.38B | — | -23.3% |
| Capital expenditure | -$235.40M | -$359.80M | -$311.40M | -$243.20M | — | +34.6% |
| Investing cash flow | -$1.37B | -$799.20M | -$4.10B | $1.58B | — | -71.6% |
| Share buybacks | — | $0 | $0 | -$750.00M | -$1.80B | — |
| Financing cash flow | -$301.90M | -$683.50M | $149.30M | -$1.75B | — | +55.8% |
| Free cash flow | $1.97B | $2.52B | $1.24B | $1.14B | — | -21.7% |
| End cash position | $3.01B | $2.38B | $1.05B | $3.42B | — | +26.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $2.74B | $2.48B | $2.28B | $2.53B | $2.65B | — | +10.4% |
| Operating revenue | $2.74B | $2.48B | $2.28B | $2.53B | $2.65B | — | +10.4% |
| Cost of revenue | $776.90M | $661.00M | $495.50M | $674.40M | $605.00M | — | +17.5% |
| Gross profit | $1.96B | $1.82B | $1.78B | $1.86B | $2.04B | — | +7.8% |
| Research & development | $529.60M | $539.00M | $509.40M | $436.10M | $399.00M | — | -1.7% |
| Selling, general & admin | $709.70M | $607.30M | $682.50M | $594.80M | $583.80M | — | +16.9% |
| Total operating expense | $1.48B | $1.36B | $1.40B | $1.25B | $1.19B | — | +8.8% |
| Operating income | $482.80M | $459.80M | $385.50M | $606.50M | $851.80M | — | +5.0% |
| Net interest income | -$57.00M | -$29.70M | -$30.30M | -$35.80M | -$40.30M | — | -91.9% |
| Pre-tax income | $132.40M | $377.70M | -$56.00M | $557.30M | $744.00M | — | -64.9% |
| Tax provision | $34.90M | $58.20M | -$7.10M | $90.80M | $109.20M | — | -40.0% |
| Net income | $97.50M | $319.50M | -$48.90M | $466.50M | $634.80M | — | -69.5% |
| Net income to common | $97.50M | $319.50M | -$48.90M | $466.50M | $634.80M | — | -69.5% |
| Basic EPS | 0.66 | 2.17 | -0.33 | — | 4.33 | 1.65 | -69.6% |
| Diluted EPS | 0.66 | 2.15 | -0.33 | — | 4.33 | 1.64 | -69.3% |
| EBIT | $214.70M | $445.30M | $11.50M | $624.70M | $816.60M | — | -51.8% |
| EBITDA | $450.80M | $649.70M | $211.70M | $826.90M | $1.01B | — | -30.6% |
| Basic shares | 147.70M | 147.20M | 146.70M | — | 146.50M | 146.10M | +0.3% |
| Diluted shares | 148.70M | 148.40M | 146.70M | — | 146.70M | 146.60M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.28B | $3.38B | $3.01B | $3.86B | $2.76B | — | -62.0% |
| Cash & short-term investments | $1.28B | $4.28B | $3.82B | $3.96B | $2.76B | — | -70.0% |
| Accounts receivable | $2.40B | $1.79B | $1.87B | $1.85B | $2.08B | — | +34.0% |
| Inventory | $2.38B | $1.95B | $2.17B | $2.21B | $2.27B | — | +22.3% |
| Total current assets | $7.31B | $9.19B | $8.97B | $8.94B | $7.97B | — | -20.5% |
| Property, plant & equipment | $3.24B | $3.27B | $3.32B | $3.41B | $3.43B | — | -0.9% |
| Goodwill & intangibles | $20.51B | $15.54B | $15.67B | $15.82B | $15.96B | — | +31.9% |
| Total assets | $32.09B | $29.48B | $29.44B | $29.21B | $28.33B | — | +8.8% |
| Total current liabilities | $3.92B | $3.00B | $3.35B | $3.29B | $3.18B | — | +30.6% |
| Current debt | $800.00M | — | — | — | — | $1.75B | — |
| Long-term debt | $7.29B | $6.29B | $6.29B | $6.29B | $6.28B | — | +15.9% |
| Total debt | $8.36B | $6.56B | $6.58B | $6.59B | $6.59B | — | +27.3% |
| Total liabilities | $13.24B | $10.83B | $11.18B | $11.00B | $10.70B | — | +22.2% |
| Retained earnings | $20.97B | $20.87B | $20.55B | $20.60B | $20.14B | — | +0.5% |
| Shareholder equity | $18.85B | $18.65B | $18.26B | $18.21B | $17.63B | — | +1.1% |
| Working capital | $3.39B | $6.19B | $5.62B | $5.65B | $4.78B | — | -45.3% |
| Net tangible assets | -$1.66B | $3.11B | $2.59B | $2.38B | $1.67B | — | -153.4% |
| Shares issued | 147.70M | 171.40M | 170.60M | 170.50M | 170.40M | — | -13.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $97.50M | $319.50M | -$48.90M | $466.50M | $634.80M | -69.5% |
| Depreciation & amortisation | $236.10M | $204.40M | $200.20M | $202.20M | $194.30M | +15.5% |
| Stock-based compensation | $77.40M | $84.00M | $59.60M | $75.30M | $74.90M | -7.9% |
| Change in working capital | -$238.10M | -$127.90M | -$108.70M | $174.20M | -$789.60M | -86.2% |
| Operating cash flow | $448.90M | $645.50M | $511.90M | $1.27B | $160.90M | -30.5% |
| Capital expenditure | -$140.90M | -$86.20M | -$110.20M | -$51.50M | -$26.60M | -63.5% |
| Investing cash flow | -$3.84B | -$209.50M | -$1.23B | -$35.10M | -$57.00M | -1,732.6% |
| Financing cash flow | $1.30B | -$43.80M | -$137.00M | -$130.20M | -$11.70M | +3,058.9% |
| Free cash flow | $308.00M | $559.30M | $401.70M | $1.22B | $134.30M | -44.9% |
| End cash position | $1.28B | $3.38B | $3.01B | $3.86B | $2.76B | -62.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $2.64B | +4.0% |
| Next quarter | — | — | $2.60B | +14.1% |
| Current year | — | — | $10.44B | +5.6% |
| Next year | — | — | $10.66B | +2.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.19%
Held by institutions99.52%
Institutions holding1.49K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
181.18
+1.13% from price
SMA 20
179.60
+2.01% from price
SMA 50
178.04
+2.91% from price
SMA 100
169.60
+8.03% from price
SMA 200
161.13
+13.71% from price
EMA 12
181.64
+0.87% from price
EMA 26
179.53
+2.05% from price
EMA 50
176.83
+3.61% from price
RSI (14)
53.9
Neutral
MACD (12,26,9)
2.11
Hist 0.79
ATR (14)
3.70
2.02% of price
Realised vol 30D
51.2%
Annualised
Bollinger upper
187.92
20, 2σ
Bollinger lower
171.28
20, 2σ
50 / 200 cross
Golden
178.04 vs 161.13
Trend bias
Above 200
+13.71%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.41
Less volatile than market
Correlation to SPY
-0.14
Largely independent
Realised vol 30D
51.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-13.9%
Peak to trough
Max drawdown 5Y
-66.5%
Peak to trough
ATR 14
3.70
2.02% of price
Beta (reported)
0.16
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Wolfe Research | UPGRADE | Peer Perform | Outperform |
| Aug 4, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Aug 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 30, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 30, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 30, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 30, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Wedbush | MAINTAINED | Neutral | Neutral |
| Jul 29, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 21, 26 | Guggenheim | MAINTAINED | Buy | Buy |
Headlines
Dow Jones Futures Waver; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 11m ago
Gold, silver rally off ugly crash, but investors remain on edge
TheStreet · 14m ago
Gauff powers past Pegula to win US Open warm-up in Cincinnati
AFP · 15m ago
Shein to make market debut in Hong Kong in September
AFP · 17m ago
Alibaba set to open down 8% in Hong Kong after $10.2 billion share placement plan
Reuters · 18m ago
RKLB Stock Rockets Toward Best Month Since May: ‘Hungry Hippo’ Begins Flight-Like Testing Ahead Of Neutron Debut
Stocktwits · 20m ago
Japan's Olympic figure skating heroes to wed
AFP · 22m ago
Fils tops Tiafoe to claim first ATP Masters title in Cincinnati
AFP · 28m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.